7 completed, 5 unknown, 3 terminated. 15 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 15 | Completed 7, Unknown 5, Terminated 3 |
Follow Ovarian Hyperstimulation Syndrome: new trials by email Literature Review of Ovarian Hyperstimulation Syndrome trials Research Report on Ovarian Hyperstimulation Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Coasting Versus Antagonist Protocol in Patients at High Risk of OHSS Gonadotropin, Antagonist - Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | ClinAmygate | 300 | 2019-07-01 | 2019-11-21 |
| Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome Pregnyl (1,500) IU, 1.5 mL of normal saline - Ovarian Hyperstimulation Syndrome, Infertility, Female | Phase 4 | Unknown | Mount Sinai Hospital, Canada | 80 | 2019-05-01 | 2023-07-03 |
| Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders Synarel, 0.2 Mg/Inh Nasal Spray, Estrofem, Utrogestan - Pregnancy Early, Miscarriage | Phase 4 | Unknown | Assaf-Harofeh Medical Center | 100 | 2017-12-29 | 2021-04-01 |
| Preventive Application of GnRH Antagonist on Early OHSS GnRH antagonist, aspirin - Ovarian Hyperstimulation Syndrome, GnRH Antagonist | Phase 4 | Unknown | First Affiliated Hospital, Sun Yat-Sen University | 175 | 2017-01-01 | 2017-06-15 |
| Corifollitropin Alfa Application in PCOS Patients Corifollitropin alfa - In Vitro Fertilization | Phase 4 | Unknown | Shin Kong Wu Ho-Su Memorial Hospital | 30 | 2014-01-01 | 2014-08-13 |
| Low-dose Gonal-f® in Ovulation Induction Gonal-f® - Infertility, Monofollicular Development | Phase 4 | Terminated | Merck KGaA, Darmstadt, Germany | 24 | 2013-07-01 | 2016-08-11 |
| Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS hCG - Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | UConn Health | 89 | 2013-03-01 | 2018-10-26 |
| Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome? Triptorelin 0.2 mg - Ovarian Hyperstimulation Syndrome | Phase 4 | Terminated | Elisha Hospital | 6 | 2012-11-01 | 2015-08-04 |
| Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation GnRH agonist, hCG - Endometrial Receptivity, Ovarian Hyperstimulation Syndrome | Phase 4 | Terminated | UConn Health | 7 | 2012-04-01 | 2018-11-21 |
| Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS letrozole, Aspirin - Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | First Affiliated Hospital, Sun Yat-Sen University | 100 | 2012-01-01 | 2016-02-01 |
| Endometrial Receptivity After GnRH Agonist Triggering hCG, triptorelin, Triptorelin, estradiol valerate, micronized vaginal progesterone - Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | IVI Madrid | 35 | 2011-11-01 | 2016-10-26 |
| Short Versus Long Protocol for IVF and IVF+ICSI Patients receiving short protocol IVF/ICSI-treatment., Long protocol - Infertility, Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | Peter Hornnes, MD, DMSc | 1099 | 2009-01-01 | 2016-01-13 |
| Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles Buserelin and Pregnyl, Pregnyl - OHSS (Ovarian Hyperstimulation) | Phase 4 | Completed | Regionshospitalet Viborg, Skive | 384 | 2009-01-01 | 2013-11-27 |
| The Use of GnRH Agonist Trigger in the Prevention of OHSS Leuprolide acetate - Ovarian Hyperstimulation Syndrome | Phase 4 | Completed | University of Connecticut | 66 | 2004-08-01 | 2006-07-06 |
| Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients Arvekap 0.1mg (Triptorelin, Ipsen, France), Ganirelix 0.25mg (Orgalutran, Organon, The Netherlands) - Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome | Phase 4 | Unknown | Eugonia | 200 | 2003-11-01 | 2006-12-29 |
Polycystic Ovary Syndrome (3) · Infertility (2) · Abortion, Spontaneous (1) · Infertility, Female (1)
Adnexal Diseases (15) · Endocrine System Diseases (15) · Female Urogenital Diseases (15) · Female Urogenital Diseases and Pregnancy Complications (15) · Genital Diseases (15) · Genital Diseases, Female (15) · Gonadal Disorders (15) · Ovarian Diseases (15) · Urogenital Diseases (15) · Cysts (3) · Neoplasms (3) · Ovarian Cysts (3) · Infertility (1) · Pregnancy Complications (1)
Chorionic Gonadotropin (4) · Triptorelin Pamoate (3) · Aspirin (2) · Estradiol (2) · Leuprolide (2) · 17 alpha-Hydroxyprogesterone Caproate (1) · Buserelin (1) · Glycoprotein Hormones, alpha Subunit (1) · Gonadotropin-Releasing Hormone (1) · Gonadotropins (1) · LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1) · Letrozole (1) · Nafarelin (1) · Profasi (1) · Progesterone (1)
First Affiliated Hospital, Sun Yat-Sen University (2) · UConn Health (2) · Assaf-Harofeh Medical Center (1) · ClinAmygate (1) · Elisha Hospital (1) · Eugonia (1) · IVI Madrid (1) · Merck KGaA, Darmstadt, Germany (1) · Mount Sinai Hospital, Canada (1) · Peter Hornnes, MD, DMSc (1) · Regionshospitalet Viborg, Skive (1) · Shin Kong Wu Ho-Su Memorial Hospital (1) · University of Connecticut (1)
United States (3) · Denmark (2) · Israel (2) · Canada (1) · China (1) · Egypt (1) · Greece (1) · Ireland (1) · Spain (1) · Taiwan (1) · United Kingdom (1)
Lawrence Engmann, MD (2) · Alfonso Bermejo, MD (1) · Claudio Benadiva, MD (1) · Eman Elgendy, MD (1) · Helle Meinertz (1) · Jiann-Loung Hwang, MD (1) · Lawrence Engmann, MD, MRCOG (1) · Michal Youngster, MD (1) · Miguel Russo, MD (1) · Peter Hornnes (1) · Peter S Humaidan, MD (1) · Qingyun Mai (1) · Shahar Kol, MD (1) · Thue Bryndorf (1)
PMID 17854523, PMID 20008886, PMID 21601197, PMID 23753114, PMID 27060174, PMID 28130435, PMID 29175067, PMID 31227286